Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
Clinical trial NCT05354349 · COMPLETED
Trial details
- NCT number
- NCT05354349
- Sponsor
- Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2022-08-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.